Published in Lancet on January 14, 1992
Measurement of breath alcohol. Lancet (1992) 0.91
Monitoring TURP. Lancet (1991) 2.57
Monitoring TURP. Lancet (1991) 1.41
FOUR RECENT INFLUENZA EPIDEMICS: AN EXPERIMENTAL STUDY. J Clin Invest (1940) 20.40
A LATENT VIRUS IN NORMAL MICE CAPABLE OF PRODUCING PNEUMONIA IN ITS NATURAL HOST. J Exp Med (1940) 8.58
Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med (1992) 4.33
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70
Malignant pulmonary neoplasms predisposing to spontaneous pneumothorax. Mayo Clin Proc (1973) 1.66
Volume kinetics of Ringer solution, dextran 70, and hypertonic saline in male volunteers. Anesthesiology (1997) 1.64
Obstetric ultrasound by family physicians. J Fam Pract (1992) 1.55
Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs (1991) 1.53
Time course of increased haemodilution in hypotension induced by extradural anaesthesia. Br J Anaesth (1996) 1.45
Hydroxyethyl starches and dextran during hip replacement surgery: effects on blood volume and coagulation. Acta Anaesthesiol Scand (2011) 1.42
Progressive decrease in glucose clearance during surgery. Acta Anaesthesiol Scand (2006) 1.42
Fluid absorption and the long-term outcome after transcervical resection of the endometrium. Acta Obstet Gynecol Scand (1998) 1.39
Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer (1974) 1.37
Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst (1975) 1.32
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer. Cancer Chemother Rep (1975) 1.25
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep (1974) 1.24
Symptoms of the transurethral resection syndrome using glycine as the irrigant. J Urol (1995) 1.20
Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer (1989) 1.18
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. Cancer Chemother Rep (1972) 1.13
Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. Urology (2001) 1.12
Differences in arginine requirement for growth among arginine-utilizing Mycoplasma species. J Bacteriol (1974) 1.11
Combination chemotherapy in gastrointestinal cancer. Cancer Res (1970) 1.08
Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer (1974) 1.08
Ethics of infusing irrigating fluid. Acta Anaesthesiol Scand (2008) 1.07
'Double toxicity' of glycine solution in the mouse. Br J Urol (1996) 1.06
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med (1987) 1.05
Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg (1985) 1.04
Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine. Br J Clin Pharmacol (2000) 1.03
Volume kinetics of Ringer's solution in hypovolemic volunteers. Anesthesiology (1999) 1.02
Distribution of ethanol and water between plasma and whole blood; inter- and intra-individual variations after administration of ethanol by intravenous infusion. Scand J Clin Lab Invest (1990) 1.02
Volume kinetics of glucose 2.5% solution during laparoscopic cholecystectomy. Br J Anaesth (2004) 1.02
Family practice obstetric ultrasound in an urban community health center. Birth outcomes and examination accuracy of the initial 227 cases. J Fam Pract (1990) 1.01
Concentration-time profiles of ethanol in arterial and venous blood and end-expired breath during and after intravenous infusion. J Forensic Sci (1997) 1.01
Pharmacokinetics of ethanol in plasma and whole blood: estimation of total body water by the dilution principle. Eur J Clin Pharmacol (1992) 0.99
A comparison of 5-fluorouracil administered by slow infusion and rapid injection. Cancer Res (1972) 0.99
Pelvic pain from cholelithiasis in a patient with kyphoscoliosis. Am Fam Physician (1995) 0.98
High-dose ropivacaine wound infiltration for pain relief after inguinal hernia repair: a clinical and pharmacokinetic evaluation. Reg Anesth Pain Med (1998) 0.97
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report. Cancer (1978) 0.96
Validation of volume kinetic analysis of glucose 2.5% solution given by intravenous infusion. Br J Anaesth (2003) 0.96
Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. Cancer Res (1975) 0.95
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. Cancer Chemother Rep (1975) 0.95
Simulated intraperitoneal absorption of irrigating fluid. Acta Obstet Gynecol Scand (1995) 0.94
Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. Cancer Treat Rep (1982) 0.94
Mitomycin C therapy in advanced gastrointestinal cancer. JAMA (1968) 0.94
Do ethanol and deuterium oxide distribute into the same water space in healthy volunteers? Alcohol Clin Exp Res (2001) 0.93
Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis. JAMA (1979) 0.93
Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra-abdominal bleeding. J Trauma (1998) 0.93
Diagnostic ultrasound imaging by physicians of first contact: extending the family medicine experience into emergency medicine. Ann Emerg Med (1993) 0.91
Blood loss during transurethral resection of the prostate as measured by the HemoCue photometer. Scand J Urol Nephrol (1993) 0.91
Comparative poliovirus permeability of silver, polycarbonate, and cellulose membrane filters. Appl Microbiol (1970) 0.89
Pain relief by wound infiltration with bupivacaine or high-dose ropivacaine after inguinal hernia repair. Reg Anesth Pain Med (1999) 0.89
Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med (1997) 0.89
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol (1982) 0.89
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer (1975) 0.89
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Clin Pharmacol Ther (1976) 0.87
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. Cancer Treat Rep (1976) 0.87
Cardiopulmonary resuscitation in a university hospital. An analysis of survival and cost. West J Med (1979) 0.86
Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer. Cancer Treat Rep (1978) 0.86
Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer (1980) 0.86
Primary anterior mediastinal seminoma. Cancer (1982) 0.86
The kinetics of Ringer's solution in young and elderly patients during induction of general anesthesia with propofol and epidural anesthesia with ropivacaine. Acta Anaesthesiol Scand (2007) 0.85
Volume kinetics of Ringer's solution during induction of spinal and general anaesthesia. Br J Anaesth (2001) 0.85
Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction. BJU Int (2003) 0.85
A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer. Cancer (1992) 0.85
Volume kinetics of glucose 2.5% solution and insulin resistance after abdominal hysterectomy. Br J Anaesth (2004) 0.85
Volume kinetics of glucose solutions given by intravenous infusion. Br J Anaesth (2001) 0.85
Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder? Mayo Clin Proc (1988) 0.84
Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer. Cancer Chemother Rep (1971) 0.84
Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. Cancer Chemother Rep (1974) 0.84
Efficacy of subcutaneous and topical local anaesthesia for pain relief after resection of malignant breast tumours. Eur J Surg (2001) 0.84
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer (1990) 0.83
Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy? Cancer (1991) 0.83
Correlation of emergency department radiographs: results of a quality assurance review in an urban community hospital setting. J Am Board Fam Pract (1993) 0.83
Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer. Cancer Chemother Rep (1975) 0.83
Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma. Cancer Chemother Rep (1975) 0.83
Intra-operative colloid administration increases the clearance of a post-operative fluid load. Acta Anaesthesiol Scand (2009) 0.83
Serum potassium levels after induction of epidural anaesthesia using mepivacaine with and without adrenaline. Acta Anaesthesiol Scand (1991) 0.83
A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion. Cancer Res (1967) 0.82
Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer. Cancer Treat Rep (1976) 0.82
An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. N Engl J Med (1977) 0.82
Glomerular filtration rate is increased in burn patients. Burns (2010) 0.82
Training in obstetric sonography in family medicine residency programs: results of a nationwide survey and suggestions for a teaching strategy. J Am Board Fam Pract (1994) 0.82
Reliability of clinical assessment of fluid absorption in transurethral prostatic resection. Eur Urol (1993) 0.82
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer (1992) 0.82
Monitoring of fluid absorption with nitrous oxide during transurethral resection of the prostate. Acta Anaesthesiol Scand (2008) 0.81
Comparison of urological irrigating fluids containing glycine and mannitol in volunteers. Prostate (1999) 0.81
Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer. Cancer Treat Rep (1987) 0.81
A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys (1980) 0.81
Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma. Cancer Chemother Rep (1976) 0.81
Stability of the interstitial matrix after crystalloid fluid loading studied by volume kinetic analysis. Br J Anaesth (1999) 0.81
Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma. Cancer Chemother Rep (1976) 0.80
Chemotherapy of malignant hepatomas with sequential intraarterial doxorubicin and systemic 5-fluorouracil and semustine. Cancer (1988) 0.80
Glycine toxicity after high-dose i.v. infusion of 1.5% glycine in the mouse. Br J Anaesth (1999) 0.80
Effect of irrigating fluids and prostate tissue extracts on isolated cardiomyocytes. Urology (1995) 0.80
Mental status after transurethral resection of the prostate. Eur Urol (1994) 0.80